68 related articles for article (PubMed ID: 17445464)
41. A selective small molecule inhibitor of c-Met, PHA665752, inhibits tumorigenicity and angiogenesis in mouse lung cancer xenografts.
Puri N; Khramtsov A; Ahmed S; Nallasura V; Hetzel JT; Jagadeeswaran R; Karczmar G; Salgia R
Cancer Res; 2007 Apr; 67(8):3529-34. PubMed ID: 17440059
[TBL] [Abstract][Full Text] [Related]
42. [Challenge and up-to-date of molecule target therapy in lung cancer].
Han BH
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Feb; 30(2):83-5. PubMed ID: 17445464
[No Abstract] [Full Text] [Related]
43. Targeted therapy for non-small cell lung cancer.
Toloza EM; D'Amico TA
Semin Thorac Cardiovasc Surg; 2005; 17(3):199-204. PubMed ID: 16253823
[TBL] [Abstract][Full Text] [Related]
44. Angiogenesis inhibitors in the treatment of small cell and non-small cell lung cancer.
Blackhall FH; Shepherd FA
Hematol Oncol Clin North Am; 2004 Oct; 18(5):1121-41, ix. PubMed ID: 15474338
[TBL] [Abstract][Full Text] [Related]
45. Advances in target therapy for lung cancer.
Mitsudomi T
Jpn J Clin Oncol; 2010 Feb; 40(2):101-6. PubMed ID: 20031962
[TBL] [Abstract][Full Text] [Related]
46. Signal transduction pathways as novel therapy targets in lung cancer.
Reinmuth N; Mesters RM; Bieker R; Hoffknecht P; Berdel WE; Thomas M
Lung Cancer; 2004 Aug; 45 Suppl 2():S177-86. PubMed ID: 15552798
[TBL] [Abstract][Full Text] [Related]
47. COX-2 inhibitor as a radiation enhancer: new strategies for the treatment of lung cancer.
Saha D; Pyo H; Choy H
Am J Clin Oncol; 2003 Aug; 26(4):S70-4. PubMed ID: 12902860
[TBL] [Abstract][Full Text] [Related]
48. Vascular endothelial growth factor trap in non small cell lung cancer.
Riely GJ; Miller VA
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4623-7. PubMed ID: 17671153
[TBL] [Abstract][Full Text] [Related]
49. Multitargeted inhibitors in lung cancer: new clinical data.
Bar J; Herbst RS; Onn A
Clin Lung Cancer; 2008; 9 Suppl 3():S92-9. PubMed ID: 19419930
[TBL] [Abstract][Full Text] [Related]
50. The role of targeted agents in adjuvant therapy for non-small cell lung cancer.
Kelly K
Clin Cancer Res; 2005 Jul; 11(13 Pt 2):5027s-5029s. PubMed ID: 16000608
[TBL] [Abstract][Full Text] [Related]
51. Advances in the biology of lung cancer chemoprevention.
Hirsch FR; Lippman SM
J Clin Oncol; 2005 May; 23(14):3186-97. PubMed ID: 15886305
[TBL] [Abstract][Full Text] [Related]
52. Treatment of metastatic non-small-cell lung cancer.
Johnson DH; Sandler A
Chest Surg Clin N Am; 2001 Feb; 11(1):133-64. PubMed ID: 11253595
[TBL] [Abstract][Full Text] [Related]
53. Incorporating bortezomib into the treatment of lung cancer.
Davies AM; Lara PN; Mack PC; Gandara DR
Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4647-51. PubMed ID: 17671158
[TBL] [Abstract][Full Text] [Related]
54. [Photodynamic therapy for multiple primary lung cancer].
Konaka C; Okunaka T; Furukawa K; Sakai H; Kato H
Gan To Kagaku Ryoho; 1996 Jan; 23(1):31-5. PubMed ID: 8546466
[TBL] [Abstract][Full Text] [Related]
55. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
Motadi LR; Misso NL; Dlamini Z; Bhoola KD
Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
[TBL] [Abstract][Full Text] [Related]
56. [Photodynamic therapy of centrally located early-stage lung cancer].
Furuse K
Gan To Kagaku Ryoho; 1996 Jan; 23(1):27-30. PubMed ID: 8546465
[TBL] [Abstract][Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
